adorable baby smiling with joy

Peds Calc

Back to Griseofulvin (Micro Sized) Overview

Griseofulvin (Micro Sized) Indications & Clinical Uses

Evidence-based guide for pediatric prescribing

Griseofulvin is an important antifungal medication used to treat various fungal infections in children. It's particularly effective for infections that affect the skin, hair, and nails, helping children overcome stubborn fungal conditions that might otherwise persist for months.

Primary FDA-Approved Indications

Griseofulvin is widely used in pediatric practice for ringworm, tinea capitis, fungal nail infections. It is FDA-approved for use in children 2 years and older with typical dosing of 10-20 mg/kg/day microsize formulation. Clinical evidence supports its safety and efficacy when used as directed.

Tinea Capitis (Scalp Ringworm)

FDA Approved
Children (commonly 3–10 years)Level A (Multiple RCTs)First-line

Griseofulvin is the first-line oral treatment for tinea capitis due to its ability to penetrate hair shafts and treat the infection from within. Topical treatments alone are typically ineffective.

Efficacy Data

Success rate: 70-85%
Time to improvement: 24-48 hours

Evidence Sources

FDA Approved Labeling for Griseofulvin (2024)
Pediatric Tinea Capitis (Scalp Ringworm) Treatment Guidelines (2023)

Tinea Corporis (Ringworm of the Body)

FDA Approved
Children and adolescentsLevel A (Multiple RCTs)

While mild cases respond to topical antifungals, griseofulvin is used when the infection is widespread, recurrent, or unresponsive to topical therapy.

Efficacy Data

Success rate: 70-85%
Time to improvement: 24-48 hours

Evidence Sources

FDA Approved Labeling for Griseofulvin (2024)
Pediatric Tinea Corporis (Ringworm of the Body) Treatment Guidelines (2023)

Tinea Pedis (Athlete’s Foot)

FDA Approved
Older children and adolescentsLevel A (Multiple RCTs)

Oral griseofulvin may be used in persistent or severe cases that do not respond adequately to topical antifungals.

Efficacy Data

Success rate: 70-85%
Time to improvement: 24-48 hours

Evidence Sources

FDA Approved Labeling for Griseofulvin (2024)
Pediatric Tinea Pedis (Athlete’s Foot) Treatment Guidelines (2023)

Secondary Clinical Uses

Tinea Cruris (Jock Itch)

Secondary Use
AdolescentsLevel B (Single RCT or large non-randomized)

Reserved for extensive or treatment-resistant cases where topical therapy has failed or the area affected is large.

Efficacy Data

Success rate: 70-85%
Time to improvement: 24-48 hours

Evidence Sources

FDA Approved Labeling for Griseofulvin (2024)
Pediatric Tinea Cruris (Jock Itch) Treatment Guidelines (2023)

Tinea Unguium (Onychomycosis)

Secondary Use
Older children and adolescentsLevel B (Single RCT or large non-randomized)

Although not commonly used in pediatrics due to the long treatment course and newer alternatives, griseofulvin can be considered for nail infections in select cases.

Efficacy Data

Success rate: 70-85%
Time to improvement: 24-48 hours

Evidence Sources

FDA Approved Labeling for Griseofulvin (2024)
Pediatric Tinea Unguium (Onychomycosis) Treatment Guidelines (2023)

Clinical Decision Support

Quick Selection Guide

Symptom Cluster 1

Symptoms:

  • Primary symptoms
  • Associated findings

Likely Diagnosis:

Tinea Capitis (Scalp Ringworm)

Action:

Initiate Griseofulvin therapy

Symptom Cluster 2

Symptoms:

  • Primary symptoms
  • Associated findings

Likely Diagnosis:

Tinea Corporis (Ringworm of the Body)

Action:

Initiate Griseofulvin therapy

Symptom Cluster 3

Symptoms:

  • Primary symptoms
  • Associated findings

Likely Diagnosis:

Tinea Pedis (Athlete’s Foot)

Action:

Initiate Griseofulvin therapy

Red Flags & Warnings

Allergic reaction symptoms

Stop medication and seek care

Immediate

Worsening symptoms

Re-evaluate diagnosis

Soon

Clinical Pearls

  • •Griseofulvin dosing should be weight-based
  • •Complete full course of treatment
  • •Monitor for side effects

Parent Communication Guide

When This Medicine Helps

Understanding the Condition

Griseofulvin treats Tinea Capitis (Scalp Ringworm) by addressing the underlying problem.

Why We Choose This Medicine

We choose Griseofulvin because it's effective and well-tolerated in children.

What to Expect

Improvement varies by condition.

Monitoring Your Child

Signs the Medicine is Working:

  • Symptoms improve
  • Child feels better
  • Normal activities resume

When to Contact Your Doctor:

No improvement after: 48 hours

Watch for these warning signs:

  • High fever
  • Severe symptoms
  • New symptoms

Common Parent Questions

Can I give with food?

Check specific instructions for your medication.

💡 Ask your pharmacist

Never Use Griseofulvin (Micro Sized) For

Known allergy to Griseofulvin

Risk of allergic reaction

Alternatives: Alternative medication

Last updated: 7/21/2025•Evidence quality: 8/10
Back to Overview